Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
330 participants
INTERVENTIONAL
2023-04-23
2027-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Educating Providers About Lung Screening
NCT05064046
Trial to Enhance Adherence to Multiple Guidelines
NCT00201227
Using Survey to Explore Perceptions of Adults With Low Socioeconomic Status Regarding the NutriQuébec Study
NCT03847584
Using Focus Groups to Explore Perceptions of Adults With Low Socioeconomic Status Regarding the NutriQuébec Study
NCT03849846
Cohort as Part of Undergraduate Medical Studies at the University of Sherbrooke
NCT03928509
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Arm: CVD
Patients diagnosed with mild to severe CAC and not on first line guideline recommended therapy.
Coronary artery Calcification (CAC) score obtained from lung cancer screening CT Scan images
No interventions assigned to this group
Intervention Arm: CVD
Patients diagnosed with mild to severe CAC and not on first line guideline recommended therapy.
CAC score obtained from lung cancer screening CT Scan images
Educational material and treatment recommendations for patients, general practitioners and pharmacists
Educational material and treatment recommendations given to patients, their family doctors and their pharmacists.
Control Arm: COPD
Patients with untreated COPD or not on first line guideline recommended therapy.
No interventions assigned to this group
Intervention Arm: COPD
Patients with untreated COPD or not on first line guideline recommended therapy.
Educational material and treatment recommendations for patients, general practitioners and pharmacists
Educational material and treatment recommendations given to patients, their family doctors and their pharmacists.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Educational material and treatment recommendations for patients, general practitioners and pharmacists
Educational material and treatment recommendations given to patients, their family doctors and their pharmacists.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Cardiovascular aim: mild to severe CAC identified on low dose CT, not on guideline recommended lipid-lowering therapy.
* COPD aim: diagnosed with COPD, symptomatic (mMRC \>=1 or CAT\>= 10) and untreated, or not on first line guideline recommended therapy for COPD.
Exclusion Criteria
* Cardiovascular aim: Absent CAC, known clinical atherosclerosis, known former heart surgery, Diabetes Mellitus.
* COPD aim: asymptomatic, or already on appropriate first line COPD therapy.
55 Years
74 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nicole Ezer, MD, FRCPC, MPH
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nicole Ezer, MD, FRCPC, MPH
Assistant professor of medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
McGill University Health Center
Montreal, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MP-37-2023-8641
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.